HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

PD 142676

Also Known As:

1,3-dichloro-6,7,8,9,10,12-hexahydroazepino(2,1-b)quinazoline; CI 1002; PD-142676

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinazolines: 402
      - PD 142676: 2

Experts

1.	Dorrego García, Ramón María: 1 article (03/2019)
2.	Izquierdo González, Ricardo: 1 article (03/2019)
3.	Rodríguez Ledo, Pilar: 1 article (03/2019)
4.	Segura Heras, José Vicente: 1 article (03/2019)

Related Diseases

1.	Cognitive Dysfunction 08/01/1994 - "The combined effect of AChE inhibition and muscarinic antagonism distinguishes PD 142676 from other anticholinesterases, and may be useful in treating the cognitive dysfunction of AD and produce fewer peripheral side effects."
2.	Dyslipidemias (Dyslipidemia) 03/15/2019 - "Patients with AAA were characterized by the presence of ischemic cardiopathy (Odds Ratio (OR): 4.27, 95% Confidence Interval (CI): 1.37-13.31, p = 0.012), dyslipidemia (OR: 4.99, 95% CI: 1, 07-23.31; p = 0.041), arterial hypertension (OR: 4.14, 95% CI: 1.07-15.98, p = 0.039), and a longer history of smoking (OR: 1.03; 95% CI: 1002-1.054; p = 0.037). "
3.	Hypertension (High Blood Pressure) 03/15/2019 - "Patients with AAA were characterized by the presence of ischemic cardiopathy (Odds Ratio (OR): 4.27, 95% Confidence Interval (CI): 1.37-13.31, p = 0.012), dyslipidemia (OR: 4.99, 95% CI: 1, 07-23.31; p = 0.041), arterial hypertension (OR: 4.14, 95% CI: 1.07-15.98, p = 0.039), and a longer history of smoking (OR: 1.03; 95% CI: 1002-1.054; p = 0.037). "

Related Drugs and Biologics

1.	Cholinergic Agents (Cholinergics)
2.	Cholinesterase Inhibitors (Anticholinesterases)